HOLX News and Press, Hologic Inc. From 07/18/22

BTIG has downgraded Hologic, Inc. ( NASDAQ: HOLX ), a developer of medical equipment targeting female health, to Neutral from Buy, noting mainly the macro-related issues which, according to the analysts, generally fell outside the company’s control. Noting its previ...

--New assays for the Panther Fusion and Novodiag Systems further build on Hologic’s leading molecular scalable solutions offering to European customers-- Hologic, Inc. (Nasdaq: HOLX) announced today that it is now offering its Panther Fusion ® SARS-CoV-2/Flu ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2022 on Wednesday, July 27, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern...

Hologic Taking Action with 'Hey, U!' Campaign to Educate Women in Conjunction with Fibroid Awareness Month A new survey commissioned by Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, revealed a lack of awareness among U.S. women about uterine hea...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

BofA Securities is out with a list of stocks that should benefit from a transforming world. "The changing composition of the global population in the decades to come will be transformational," BofA analysts wrote in a note. "The global population has doubled in the past 50 years, but declinin...

Glenview Capital Management’s 13F portfolio value increased from $4.69B to $4.94B this quarter. The number of positions increased from 57 to 60. They increased Cigna, DXC Technology, Fiserv, US Foods Holding, Amazon.com, and Aptiv plc while decreasing McKesson, Bausch Health, F...

Hologic presents with the economics to withstand current macroeconomic crosscurrents currently plaguing equity markets. The company's stable cash flow and free cash conversion has built a solid underweight to the investment debate. We note potential mispricing as the company's top...

-- New quantitative assays for Epstein-Barr Virus and BK Virus expand Hologic’s Panther Fusion transplant pathogen monitoring menu -- Hologic, Inc. (Nasdaq: HOLX) announced it has received CE marking for two new molecular assays, Panther Fusion EBV Quant Assay and Pan...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...